Claims for Patent: 7,723,056

Summary for Patent: 7,723,056

Title:	Particles
Abstract:	Lipid vesicle particles capable of being targeted to a cell type of interest, said particle incorporating a peptide which is responsive to a predetermined metabolic signal from the targeted cell so as to modulate the permeability of the particle, said particle further incorporating a species to be targeted to the cell which is activated on said modulation of permeability. The particles may be used in methods for detecting cells, methods of treating cells and also therapeutically.
Inventor(s):	Clarke; David J. (Sandbach, GB), Harrison; Michael H. (Glossop, GB), Aojula; Harmesh S. (Saddleworth, GB)
Assignee:	The University of Manchester (Manchester, GB)
Application Number:	09/529,342
Patent Claims:	1. A method of detecting a cell type of interest present or potentially present in a sample comprising treating the sample, in vitro or ex vivo, with lipid vesicle particles which specifically bind to said cell type of interest, said particles having at least one layer of enveloping lipids and incorporating a cytolytic peptide, which is non-covalently attached thereto, wherein said peptide, in response to a predetermined extracellular metabolic signal from said cell type of interest, if present in the sample, interacts with the layer to act as or mediate the opening of pores or channels within the lipid layer to thereby modulate the permeability of the particles, said particles further incorporating a species which is released on said modulation of permeability, wherein said species produces a detectable signal in the presence of said metabolic signal, and monitoring directly or indirectly for the species, wherein a portion of said particles have a first binding moiety and a further portion of said particles have a second binding moiety which is capable of binding with said first binding moiety whereby said particles are, or are capable of being, aggregated together, and wherein said sample is treated with said particles under conditions such that a collection of said particles is aggregated around said cell type of interest. 2. The method according to claim 1, wherein the first binding moiety is avidin or a derivative thereof, and the second binding moiety is biotin or a derivative thereof. 3. The method according to claim 1, wherein said cell type of interest is pathogenic cells. 4. The method according to claim 3, wherein said method is a method for analysing foodstuff for the presence of said pathogenic cells. 5. The method according to claim 3, wherein said method is a method for analysing water samples for the presence of said pathogenic cells. 6. A method of detecting a cell type of interest present or potentially present in a sample comprising treating the sample, in vitro or ex vivo, with lipid vesicle particles which specifically bind to said cell type of interest, said particles having at least one layer of enveloping lipids and incorporating a cytolytic peptide, which is non-covalently attached thereto, wherein said peptide, in response to a predetermined metabolic signal, which metabolic signal comprises a change in pH, from said cell type of interest, if present in the sample, interacts with the layer to act as or mediate the opening of pores or channels within the lipid layer to thereby modulate the permeability of the particles, said particles further incorporating a species which is released on said modulation of permeability, wherein said species produces a detectable signal in the presence of said metabolic signal, and monitoring directly or indirectly for the species, wherein a portion of said particles have a first binding moiety and a further portion of said particles have a second binding moiety which is capable of binding with said first binding moiety whereby said particles are, or are capable of being, aggregated together, and wherein said sample is treated with said particles under conditions such that a collection of said particles is aggregated around said cell type of interest. 7. A method of detecting a cell type of interest present or potentially present in a sample comprising treating the sample, in vitro or ex vivo, with lipid vesicle particles which specifically bind to said cell type of interest, said particles having at least one layer of enveloping lipids and incorporating a cytolytic peptide, which is non-covalently attached thereto, wherein the peptide, in response to a predetermined extracellular metabolic signal from the cell type of interest, if present in the sample, interacts with the layer to act as or mediate the opening of pores or channels within the lipid layer to thereby modulate the permeability of the particles, said particles further incorporating a species which is released on said modulation of permeability, wherein said species produces a detectable signal in the presence of said metabolic signal, and monitoring directly or indirectly for the species, wherein said cell type of interest is a bacterium. 8. The method according to claim 7 wherein said metabolic signal comprises a change in pH. 9. The method according to claim 7 wherein said sample is water. 10. The method according to claim 7 wherein said sample is a foodstuff. 11. The method according to claim 7, wherein the cytolytic peptide comprises an integral protein of the lipid layer. 12. The method according to claim 7, wherein the cytolytic peptide spans the lipid layer. 13. The method according to claim 7, wherein the cytolytic peptide is non-covalently attached to an outer lipid layer. 14. The method according to claim 7, wherein the particles comprise a binding agent capable of binding a particle to the cell type of interest when the particle is targeted thereto. 15. The method according to claim 14, wherein the binding agent is an antibody for binding to an antigen on the cell type of interest. 16. The method according to claim 7, wherein the cytolytic peptide is selected from the group consisting of GALA, Helical erythrocyte lysing peptide (HELP), KALA, and LAGA. 17. The method according to claim 7, wherein the cytolytic peptide is N, Myristic-GALA. 18. The method according to claim 7, wherein the cytolytic peptide is selected from the group consisting of Amphotericin B, Alamethicin, Gramicidin, Melittin, Nigericin, P25, Polymixin B, Valinomycin, and Vibriolsin. 19. The method according to claim 7, wherein the species is a dye. 20. The method according to claim 7, wherein the species is an enzyme. 21. The method according to claim 20, wherein the enzyme is alkaline phosphatase, .beta.-Galactosidase or asparaginase, or glucose oxidase. 22. The method according to claim 7, wherein the species is a co-factor or substrate for an enzyme. 23. The method according to claim 7, wherein the metabolic signal comprises a change in ion concentration. 24. The method according to claim 23, wherein the ion is H.sup.+, Na.sup.+, Cl.sup.-, HCO.sup.-, or K.sup.+. 25. The method according to claim 8, wherein the metabolic signal comprises a change in pH, wherein the pH is above 6. 26. The method according to claim 8, wherein the metabolic signal comprises a change in pH, wherein the pH is above 7. 27. The method according to claim 7, wherein the metabolic signal comprises a change in gas concentration. 28. The method according to claim 7, wherein the metabolic signal comprises a change in carbon dioxide concentration. 29. A method of detecting a cell type of interest present or potentially present in a sample comprising treating the sample, in vitro or ex vivo, with lipid vesicle particles which specifically bind to said cell type of interest, said particles having at least one layer of enveloping lipids and incorporating a cytolytic peptide, which is non-covalently attached thereto, wherein the peptide, in response to a predetermined extracellular metabolic signal from the cell type of interest, if present in the sample, interacts with the layer to act as or mediate the opening of pores or channels within the lipid layer to thereby modulate the permeability of the particles, said particles further incorporating a species which is released on said modulation of permeability, wherein said species produces a detectable signal in the presence of said metabolic signal, and monitoring directly or indirectly for the species, wherein said cell type of interest is a pathogenic cell. 30. The method according to claim 29 wherein said metabolic signal comprises a change in pH. 31. The method according to claim 29 wherein said sample is water. 32. The method according to claim 29 wherein said sample is a foodstuff.

Details for Patent 7,723,056

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2017-10-16